Innophos Nutrition Inc. has signed an exclusive US distribution agreement with Japan’s Theravalues Corporation. The deal provides for Innophos Nutrition to sell, market and distribute Theravalues’ Theracurmin® and EMIQ® products.
Innophos Nutrition is a leading manufacturer and distributor of premium ingredients and blends to the nutritional and natural products industries; and a subsidiary of Innophos Holdings Inc. (NASDAQ: IPHS).
“We developed patented technologies to make highly bioavailable Theracurmin® and EMIQ®, increasing bioavailability for more efficient dosages then invested in successful human clinical trials,” says Tadashi Hashimoto, representative director and president of Theravalues Corporation. “I am confident and enthusiastic that this strategic partnership with Innophos Nutrition will accelerate the expansion of these fantastic ingredients and consequently, improve health and wellness of people in the USA.”
Officials say that human clinical studies show Theracurmin® is 27 times more bioavailable than standard curcumin powder. Dispersible in water, heat and light stable, it is ideal for a variety of delivery forms. One of the most researched curcumin ingredients on the market, Theracurmin® has 19 completed human clinical trials and 15 ongoing studies to continue to show its benefits on human health.
Enzymatically-modified isoquercitrin (EMIQ®) is a water-soluble polyphenol derived from rutin. In multiple human clinical studies, EMIQ® is 17 times more bioavailable than quercetin. That research also indicates EMIQ® increases markers of body fat metabolism and is a powerful antioxidant that supports the immune system and cellular health.
"We are excited about the addition of Theracurmin® and EMIQ® into our signature ingredient portfolio,” says Bruce Brown, vice president, Innophos Nutrition. “Theracurmin® is the most clinically studied and versatile curcumin product on the market. EMIQ® is a unique, water-soluble and highly active polyphenol. Both Theracurmin® and EMIQ® deliver superior health benefits and extensive formulation opportunities.”
“Theravalues Corporation shares our commitment to innovation and high-quality products,” adds
Joseph Golowski, president, Innophos Nutrition. “We look forward to working together as we provide customers with access to these exciting ingredients.”